Skip to content

MaxCyte MXCT Intangibles (Net)

Intangibles (Net) at other companies

Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$166.8M+73.8%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
$48.86M-28.9%
PDE
Pro-Dex, Inc.PDEX
$712K+2,058%
Repligen logo
RepligenRGEN
$368.19M-10.0%
TEC
Bio-TechneTECH
$319.07M-28.1%
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
$633M-2.6%

Other financials

Income statement

See full
Revenue$9.7M-7.1%
Gross profit$8.1M-9.1%
Operating income-$6.2M+49.7%
Net income-$4.8M+53.7%
EPS (diluted)-$0.04+60.0%

Balance sheet

See full
Cash & equivalents$14.6M-37.8%
Total debt$17.5M-7.1%
Total equity$167.9M-15.8%
Total assets$194.5M-15.4%

Cash flow

See full
Operating cash flow-$8.2M+43.3%
CapEx$72.0K-89.0%
Free cash flow-$8.2M+45.3%

Valuation

See full
Market cap$130.15M-46.8%
Enterprise value$133.08M-46.3%
P/S-2.8×

Profitability

See full
Gross margin80.5%-0.4pp
Operating margin-141.8%+6.4pp
Net margin-121.2%+12.3pp
FCF margin-90.9%+3.7pp

Returns & leverage

See full
Return on equity-21.3%+2.0pp
Debt / equity0.1×0.0×
Current ratio12×-0.2×

Where this comes from

Reported directly by MaxCyte in its filing.

Tagged under the XBRL concept us-gaap:IntangibleAssetsNetExcludingGoodwill.

The official record: MaxCyte’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about MaxCyte's intangibles (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MaxCyte's intangibles (net)?
MaxCyte (MXCT) reported intangibles (net) of $783K in Q1 2026.
How has MaxCyte's intangibles (net) changed year-over-year?
MaxCyte's intangibles (net) increased by 57.2% year-over-year, from $498K to $783K.
What does intangibles (net) mean?
Identifiable intangible assets (patents, trademarks, customer relationships, technology) net of accumulated amortization — excluding goodwill.